Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: Implications for ischemic vascular diseases

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 1, 2003, Pages 9-16

  Marcus, Aaron J ^a,b   Broekman, M Johan ^a,b   Drosopoulos, Joan H F ^a,b   Islam, Naziba ^a,b   Pinsky, David J ^c   Sesti, Casilde ^a   Levi, Roberto ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Vet Aff NY Harbor Healthcare Syst   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; ECTONUCLEOTIDASE 1; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL OCCLUSION; BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; ENDOTHELIUM CELL; EXOCYTOSIS; GUINEA PIG; HEART PROTECTION; HEMOSTASIS; ISCHEMIA; METABOLIC REGULATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; REVIEW; SITE DIRECTED MUTAGENESIS; THROMBOCYTE ACTIVATION; VASCULAR DISEASE;

ANIMALS; ANTIGENS, CD; APYRASE; BRAIN ISCHEMIA; CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; MUTAGENESIS, SITE-DIRECTED; NUCLEOTIDES; PLATELET AGGREGATION INHIBITORS; SYMPATHETIC NERVOUS SYSTEM; THROMBOSIS; VASCULAR DISEASES;

EID: 0037381237     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.043729     Document Type: Review

References (47)

1. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, and Yusuf S (1996) Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 94:690-697.
2. Birk AV, Bubman D, Broekman MJ, Robertson HD, Drosopoulos JHF, Marcus AJ, and Szeto HH (2002) Role of a novel soluble nucleotide phosphohydrolase from sheep plasma in inhibition of platelet reactivity. J Lab Clin Med 139:116-124.
3. Boehm S (1999) ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 19:737-746.
4. Braunwald E and Sobel BE (1988) Coronary blood flow and myocardial ischemia, in Heart Disease, a Textbook of Cardiovascular Medicine (Braunwald E ed) pp 1191-1221, W. B. Saunders Company, Philadelphia.
5. Broekman MJ, Eiroa AM, and Marcus AJ (1991) Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension. Blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 78:1033-1040.
6. Burnstock G (1999) Current status of purinergic signalling in the nervous system. Prog Brain Res 120:3-10.
7. Choudhri TF, Hoh BL, Zerwes HG, Prestigiacomo CJ, Kim SC, Connolly ES, Kottirsch G, and Pinsky DJ (1998) Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Investig 102:1301-1310.
8. 2+ utilization by soluble human CD39/ecto-nucleotidase. Arch Biochem Biophys 406:85-95.
9. Drosopoulos JHF, Broekman MJ, Islam N, Maliszewski CR, Gayle RB, III and Marcus AJ (2000) Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39. Requirement of glutamate174 and serine218 for enzyme activity and inhibition of platelet recruitment. Biochemistry 39:6936-6943.
10. Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS, Imai M, Edelberg JM, Rayburn H, Lech M, et al. (1999) Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017.
11. Gachet C (2001) ADP receptors of platelets and their inhibition. Thromb Haemostasis 86:222-232.
12. Gayle RB III, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JHF, Islam N, et al. (1998) Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Investig 101:1851-1859.
13. Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309-319.
14. Handa M and Guidotti G (1996) Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). Biochem Biophys Res Commun 218:916-923.
15. Heyns AP, van den Berg DJ, Potgieter GM, and Retief FP (1974) The inhibition of platelet aggregation by an aorta intima extract. Thromb Diath Haemorrh 32:417-431.
16. Hollopeter G, Jantzen H-M, Vincent D, Li G, England L, Ramakrishnan V, Yang R-B, Nurden P, Nurden A, Julius D, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond) 409:202-207.
17. Ignarro LJ, Buga GM, and Chaudhuri G (1988) EDRF generation and release from perfused bovine pulmonary artery and vein. Eur J Pharmacol 149:79-88.
18. Imamura M, Lander HM, and Levi R (1996) Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemis - comparison with adenosine A1-receptors and α2-adrenoceptors. Circ Res 78:475-481.
19. 3-receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 271:1259-1266.
20. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, and Robson SC (1996) Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 271:33116-33122.
21. Kansas GS, Wood GS, and Tedder TF (1991) Expression, distribution and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 146:2235-2244.
22. Karim S, Habib A, Levy-Toledano S, and Maclouf J (1996) Cyclooxygenases-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem 271:12042-12048.
23. Konigsberg W, Kirchhofer D, Riederer MA, and Nemerson Y (2001) The TF: VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemostasis 86:757-771.
24. Kubler W and Strasser RH (1994) Signal transduction in myocardial ischaemia. Eur Heart J 15:437-445.
25. Kunicki TJ and Ruggeri ZM (2001) Platelet collagen receptors and risk prediction in stroke and coronary artery disease. Circulation 104:1451-1453.
26. Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, Baker E, Sutherland GR, Poindexter K, Birks C, et al. (1994) The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153:3574-3583.
27. Marcus AJ (1999) Platelets: their role in hemostasis, thrombosis and inflammation, in Inflammation: Basic Principles and Clinical Correlates (Gallin JI and Snyderman R eds) pp 77-95, Lippincott Williams & Wilkins, Philadelphia.
28. Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, et al. (1997) The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Investig 99:1351-1360.
29. Marcus AJ, Broekman MJ, Drosopoulos JHF, Pinsky DJ, Islam N, and Maliszewski CR (2001) Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases. Ital Heart J 2:824-830.
30. Marcus AJ, Broekman MJ, Safier LB, Ullman HL, Islam N, Serhan CN, Rutherford LE, Korchak HM, and Weissmann G (1982) Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun 109:130-137.
31. Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, and Eiroa AM (1991) Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 88:1690-1696.
32. Marcus AJ, Safier LB, Ullman HL, Islam N, Broekman MJ, Falck JR, Fischer S, and von Schacky C (1988) Platelet-neutrophil interactions. (12S)-hydroxyeicosatetraen-1, 20-dioic acid: a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroxyeicosatetraenoic acid. J Biol Chem 263:2223-2229.
33. Marcus AJ, Weksler BB, Jaffe EA, and Broekman MJ (1980) Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Investig 66:979-986.
34. Moncada S, Radomski MW, and Palmer RMJ (1988) Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37:2495-2501.
35. Mustard JF, Packham MA, and Kinlough-Rathbone RL (1974) Recent status of research in the pathogenesis of thrombosis. Thromb Haemostasis 59 (Suppl):157-188.
36. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, et al. (2002) Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Investig 109: 1031-1040.
37. Ruggeri ZM (1997) von Willebrand factor. J Clin Investig 99:559-564.
38. Ruggeri ZM (2000) Old concepts and new developments in the study of platelet aggregation. J Clin Investig 105:699-701.
39. Schafer AI, Crawford DD, and Gimbrone MA Jr (1984) Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. J Clin Investig 73:1105-1112.
40. Serhan CN and Oliw E (2001) Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Investig 107:1481-1489.
41. Sesti C, Broekman MJ, Drosopoulos JHF, Islam N, Marcus AJ, and Levi R (2002) Ectonucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. J Pharmacol Exp Ther 300:605-611.
42. 2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms. Circ Res 81:774-784.
43. Sneddon P, Westfall TD, Todorov LD, Mihaylova-Todorova S, Westfall DP, and Kennedy C (1999) Modulation of purinergic neurotransmission. Prog Brain Res 120:11-20.
44. 3 integrin receptor activation and P-selectin expression during platelet recruitment: downregulation by aspirin ex vivo. Blood 99:3978-3984.
45. Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, and Aznar J (1993) Down-regulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Investig 92:1357-1365.
46. von Kugelgen I, Allgaier C, Schobert A, and Starke K (1994) Co-release of noradrenaline and ATP from cultured sympathetic neurons. Neuroscience 61:199-202.
47. Zimmermann H and Braun N (1999) Ecto-nucleotidases-molecular structures, catalytic properties and functional roles in the nervous system. Prog Brain Res 120:371-385.